Mr. Alex Lugovoy has over 15 years of experience working in the pharmaceutical and biotechnology industries. His management consulting and operational experience span portfolio strategy, licensing, marketing, sales, medical, and R&D.
Prior to starting his own company, Dobrin Consulting, Alex started and led the “Business Development, Strategy, and M&A” department at Reckitt Benckiser Pharmaceuticals (now – Indivior), a leading global addiction pharmaceutical company where he was the Senior Manager. Prior to that role, Alex led the business development and brand management practice at Campbell Alliance, a leading healthcare management consulting company. And prior to joining Campbell Alliance, Alex was a director at Columbia Science and Technology Ventures where he oversaw the creation of 5 start-up pharmaceutical/biotech companies. Alex also worked as a Sales and Marketing Professional at Eli Lilly where he was the rookie of the year within the Sales division before going on to help launch Cymbalta as a member of the brand team.
Over the last 6 years as a head of Business Development and Strategy at Reckitt Benckiser Pharmaceuticals Alex worked to build a successful product launch, lifecycle management strategy and execution, and a full development pipeline within Reckitt Benckiser Pharmaceuticals through licensing and partnerships with the leading addiction and CNS pharmaceutical companies.
Sign up to view 0 direct reports
Get started